Yousif Capital Management LLC Has $5.72 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Yousif Capital Management LLC lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 0.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 38,194 shares of the medical research company’s stock after buying an additional 112 shares during the quarter. Yousif Capital Management LLC’s holdings in Agilent Technologies were worth $5,716,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BlueSpruce Investments LP acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $223,829,000. Massachusetts Financial Services Co. MA lifted its position in shares of Agilent Technologies by 42.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 5,851,153 shares of the medical research company’s stock worth $694,942,000 after purchasing an additional 1,736,168 shares during the period. Liontrust Investment Partners LLP acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $127,895,000. Goldman Sachs Group Inc. lifted its position in shares of Agilent Technologies by 67.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,336,607 shares of the medical research company’s stock worth $309,203,000 after purchasing an additional 942,651 shares during the period. Finally, Renaissance Technologies LLC lifted its position in shares of Agilent Technologies by 196.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,242,600 shares of the medical research company’s stock worth $164,433,000 after purchasing an additional 823,300 shares during the period.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Cowen boosted their price target on shares of Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday, November 22nd. Wells Fargo & Company upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $150.00 to $170.00 in a research report on Tuesday, January 10th. KeyCorp increased their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 22nd. StockNews.com assumed coverage on shares of Agilent Technologies in a research note on Thursday. They set a “strong-buy” rating on the stock. Finally, Jefferies Financial Group increased their target price on shares of Agilent Technologies from $158.00 to $168.00 in a research note on Tuesday, November 22nd. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $163.31.

Agilent Technologies Stock Performance

A opened at $133.18 on Friday. The company has a current ratio of 2.11, a quick ratio of 1.53 and a debt-to-equity ratio of 0.49. The company’s fifty day moving average price is $148.54 and its two-hundred day moving average price is $142.93. Agilent Technologies, Inc. has a 1-year low of $112.52 and a 1-year high of $160.26. The company has a market cap of $39.38 billion, a price-to-earnings ratio of 30.06, a PEG ratio of 1.97 and a beta of 1.04.

Agilent Technologies (NYSE:A – Get Rating) last released its quarterly earnings data on Tuesday, February 28th. The medical research company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Agilent Technologies had a net margin of 19.09% and a return on equity of 30.35%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same quarter in the prior year, the company posted $1.21 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. On average, analysts expect that Agilent Technologies, Inc. will post 5.68 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 26th. Stockholders of record on Tuesday, April 4th will be issued a $0.225 dividend. The ex-dividend date is Monday, April 3rd. This represents a $0.90 annualized dividend and a dividend yield of 0.68%. Agilent Technologies’s dividend payout ratio is currently 20.32%.

Agilent Technologies announced that its Board of Directors has approved a stock buyback plan on Monday, January 9th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical research company to buy up to 4.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.